You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 8, 2025

Drug Price Trends for DOXEPIN HCL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DOXEPIN HCL

Average Pharmacy Cost for DOXEPIN HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DOXEPIN HCL 3 MG TABLET 72578-0181-06 2.62660 EACH 2025-02-05
DOXEPIN HCL 6 MG TABLET 72578-0182-06 3.00802 EACH 2025-02-05
DOXEPIN HCL 3 MG TABLET 72819-0161-03 2.62660 EACH 2025-01-22
DOXEPIN HCL 3 MG TABLET 72205-0052-30 2.62660 EACH 2025-01-22
DOXEPIN HCL 6 MG TABLET 72819-0162-03 3.00802 EACH 2025-01-22
DOXEPIN HCL 3 MG TABLET 00228-3315-03 2.62660 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for DOXEPIN HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
DOXEPIN HCL 10MG CAP Golden State Medical Supply, Inc. 51672-4217-01 100 15.01 0.15010 EACH 2024-02-21 - 2028-06-14 FSS
DOXEPIN HCL 150MG CAP Golden State Medical Supply, Inc. 42799-0935-50 50 38.18 0.76360 EACH 2023-06-15 - 2028-06-14 FSS
DOXEPIN HCL 100MG CAP Golden State Medical Supply, Inc. 51672-4221-01 100 96.00 0.96000 EACH 2023-06-15 - 2028-06-14 FSS
DOXEPIN HCL 50MG CAP Golden State Medical Supply, Inc. 60429-0968-10 1000 465.01 0.46501 EACH 2023-06-15 - 2028-06-14 FSS
DOXEPIN HCL 50MG CAP AvKare, LLC 23155-0796-01 100 31.53 0.31530 EACH 2023-06-15 - 2028-06-14 FSS
DOXEPIN HCL 25MG CAP Golden State Medical Supply, Inc. 51672-4218-01 100 38.40 0.38400 EACH 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Doxepin Hydrochloride Market Analysis and Price Projections

Market Overview

The Doxepin Hydrochloride market has been experiencing significant growth, driven by increasing demand for treatments of major depressive disorder, anxiety disorders, chronic hives, and insomnia. Here’s a comprehensive look at the market dynamics, segmentation, and price projections.

Market Size and Growth Projections

The global Doxepin Hydrochloride market has shown robust growth and is expected to continue this trend. As of 2023, the market size was valued at several hundred million dollars, with projections indicating it will reach significantly higher values by 2031. For instance, the market is expected to grow from $412 million in 2023 to $578 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period[5].

Market Segmentation

The Doxepin Hydrochloride market is segmented based on several key factors:

By Product

  • The market is segmented into oral and topical forms. Oral forms, such as tablets, dominate the market due to their widespread use in treating various conditions[4].

By Application

  • The primary applications include major depressive disorder, anxiety disorders, chronic hives, and insomnia. The increasing prevalence of these conditions, particularly depression and anxiety, is a significant driver of market growth[1][4].

By End User

  • The market is segmented into hospitals, clinics, home care settings, and others. Hospitals and clinics are the major end-users due to the high volume of prescriptions and treatments administered in these settings[4].

By Region

  • The market is analyzed across five major regions: North America, Europe, Asia-Pacific, Middle East and Africa, and South America. Each region is further sub-segmented into respective countries to provide a detailed market outlook[3][4].

Market Dynamics

Drivers

  • The increasing prevalence of depression and anxiety disorders globally is a major driver. According to the World Health Organization, depressive disorders affected 350 million people worldwide in 2012, and this number is expected to rise due to sedentary lifestyles and other factors[4].
  • The growing geriatric population and the prevalence of sleep disorders also contribute to the market's growth.
  • Favorable reimbursement policies in developed countries for medications and therapies further boost the market[4].

Restraints

  • Common side effects such as insomnia, nausea, dry mouth, and blurry vision, along with adverse side effects like mania and suicidal tendencies, can restrict market growth[4].

Opportunities

  • The increasing demand for mental health treatments and the expanding healthcare infrastructure in developing countries present significant opportunities for market expansion.
  • Advances in pharmaceutical technology and the development of new formulations could also drive growth[3].

Challenges

  • Supply chain disruptions, such as those caused by the COVID-19 pandemic, can impact the availability and pricing of Active Pharmaceutical Ingredients (APIs), including Doxepin Hydrochloride[2].

Price Projections

Recent Trends

  • In January 2023, Doxepin Hydrochloride prices saw an upward trend globally, influenced by factors such as increased consumer demand, easing inflation, and higher quotations. This trend was particularly notable in Germany and the United States, where distributors and traders increased prices to destock inventories and place new orders[2].

Future Outlook

  • The prices of Doxepin Hydrochloride are projected to remain on the higher end due to sustained demand and the need for refilling stock levels in local markets. Downstream demands are expected to support the consistent surge in prices[2].

Key Players

The market is dominated by several key players, including:

  • Pfizer
  • Teva Pharmaceutical
  • Suzhou Homesun Pharmaceutical
  • Shanghai Pharmaceuticals
  • Lukang Pharmaceutical

These companies play a crucial role in the production and distribution of Doxepin Hydrochloride, influencing market dynamics through their strategies and innovations[5].

Regional Analysis

The market is analyzed across various regions, each with its unique trends and growth prospects:

  • North America: This region is one of the largest markets due to high healthcare spending and the prevalence of mental health disorders.
  • Europe: Similar to North America, Europe sees significant demand driven by advanced healthcare systems and favorable reimbursement policies.
  • Asia-Pacific: This region is expected to grow rapidly due to increasing healthcare infrastructure and a large patient population.
  • Middle East and Africa: These regions are also seeing growth, albeit at a slower pace, due to improving healthcare facilities and increasing awareness of mental health treatments[3][4].

Consumer Behavior and Market Trends

Consumer behavior plays a critical role in shaping the market. There is an increasing awareness and acceptance of mental health treatments, leading to higher demand for medications like Doxepin Hydrochloride. Additionally, the rise of telehealth services has made it easier for patients to access these treatments, further boosting market growth.

"The increasing geriatric population and prevalence of sleep disorders are significantly fuelling the doxepin hydrochloride market growth."[4]

Technological and Regulatory Trends

Advances in pharmaceutical technology, such as the development of new formulations and delivery systems, are expected to influence the market. Regulatory environments, including favorable reimbursement policies, also play a crucial role in driving market growth.

SWOT and PEST Analysis

A detailed SWOT analysis highlights the strengths, weaknesses, opportunities, and threats facing the market. Strengths include the increasing demand for mental health treatments and favorable reimbursement policies. Weaknesses include common and adverse side effects. Opportunities lie in expanding healthcare infrastructure and technological advancements. Threats include supply chain disruptions and regulatory changes[4].

A PEST analysis assesses the political, economic, social, and technological factors affecting the market. For instance, economic factors such as inflation and consumer demand can significantly impact pricing and market growth[4].

Key Takeaways

  • The Doxepin Hydrochloride market is expected to grow significantly, driven by increasing demand for mental health treatments.
  • The market is segmented by product, application, end-user, and region, with oral forms and major depressive disorder being key segments.
  • Key drivers include the growing prevalence of mental health disorders and favorable reimbursement policies.
  • Price projections indicate sustained higher prices due to demand and supply dynamics.
  • Major players such as Pfizer and Teva Pharmaceutical dominate the market.

FAQs

What are the primary applications of Doxepin Hydrochloride?

The primary applications include major depressive disorder, anxiety disorders, chronic hives, and insomnia.

Which regions are expected to drive the growth of the Doxepin Hydrochloride market?

North America, Europe, and the Asia-Pacific region are expected to be the major drivers of market growth due to their advanced healthcare systems and high demand for mental health treatments.

What are the key factors influencing the prices of Doxepin Hydrochloride?

Prices are influenced by consumer demand, inflation, supply chain disruptions, and the need for refilling stock levels in local markets.

Who are the major players in the Doxepin Hydrochloride market?

Major players include Pfizer, Teva Pharmaceutical, Suzhou Homesun Pharmaceutical, Shanghai Pharmaceuticals, and Lukang Pharmaceutical.

What is the projected CAGR for the Doxepin Hydrochloride market from 2023 to 2031?

The market is projected to grow at a CAGR of around 5.1% during the forecast period from 2023 to 2031[5].

Cited Sources

  1. MarketResearchIntellect: Doxepin Hydrochloride Market Size, Scope And Forecast Report.
  2. ChemAnalyst: Doxepin Hydrochloride Prices Revamped in January 2023.
  3. Cognitive Market Research: Doxepin Hydrochloride Market Report 2024 (Global Edition).
  4. The Insight Partners: Doxepin Hydrochloride Market SWOT Analysis by 2031.
  5. Valuates Reports: Global Doxepin Hydrochloride Tablets Market Research Report 2024.

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.